Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
47.30
+1.93 (4.25%)
At close: May 4, 2026, 4:00 PM EDT
47.80
+0.50 (1.06%)
Pre-market: May 5, 2026, 8:17 AM EDT
Moderna Stock Forecast
Stock Price Forecast
The 11 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $36.82, which forecasts a -22.16% decrease in the stock price over the next year. The lowest target is $18 and the highest is $69.
Price Target: $36.82 (-22.16%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 9 | 9 | 9 | 9 | 9 | 9 |
| Sell | 3 | 3 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $36 → $45 | Hold | Maintains | $36 → $45 | -4.86% | May 4, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $43 → $49 | Hold | Maintains | $43 → $49 | +3.59% | May 4, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $35 → $50 | Hold | Maintains | $35 → $50 | +5.71% | May 4, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $35 → $38 | Hold | Maintains | $35 → $38 | -19.66% | May 4, 2026 |
| Barclays | Barclays | Hold Maintains $25 → $48 | Hold | Maintains | $25 → $48 | +1.48% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
2.13B
from 1.94B
Increased by 9.67%
Revenue Next Year
2.46B
from 2.13B
Increased by 15.57%
EPS This Year
-8.33
from -7.25
EPS Next Year
-5.06
from -8.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.3B | 3.6B | ||||||
| Avg | 2.1B | 2.5B | ||||||
| Low | 1.9B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 20.1% | 68.4% | ||||||
| Avg | 9.7% | 15.6% | ||||||
| Low | -2.3% | -11.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -6.58 | -3.47 | ||||||
| Avg | -8.33 | -5.06 | ||||||
| Low | -9.55 | -6.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.